1. Volume 72, Issue 6, Pages 869-885 (December 2017)
Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review 
Michael Lardas, Matthew Liew, Roderick C. van den Bergh, Maria De Santis, Joaquim Bellmunt, Thomas Van den Broeck, Philip Cornford, Marcus G. Cumberbatch, Nicola Fossati, Tobias Gross, Ann M. Henry, Michel Bolla, Erik Briers, Steven Joniau, Thomas B. Lam, Malcolm D. Mason, Nicolas Mottet, Henk G. van der Poel, Olivier Rouvière, Ivo G. Schoots, Thomas Wiegel, Peter-Paul M. Willemse, Cathy Yuhong Yuan, Liam Bourke 
European Urology 
Volume 72, Issue 6, Pages (December 2017)
DOI: /j.eururo
Copyright © 2017 European Association of Urology Terms and Conditions

2. Fig. 1
PRISMA flow diagram. QoL=quality of life; PCa=prostate cancer; PRISMA=Preferred Reporting Items for Systematic Reviews and Meta-analyses.
European Urology  , DOI: ( /j.eururo )
Copyright © 2017 European Association of Urology Terms and Conditions

3. Fig. 2
Risk of bias and confounder assessment for (A) RCTs and (B) nonrandomised prospective studies. Red colour indicates high RoB, yellow uncertain RoB, and green low RoB. RCT=randomised controlled trial; RoB=risk of bias.
European Urology  , DOI: ( /j.eururo )
Copyright © 2017 European Association of Urology Terms and Conditions